Global Ibuprofen Market by Types (USP and EP), Dosage Forms (Tablet, Capsule, Suspension, and Others), and Regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)
Market Outlook:
The global ibuprofen market was valued at USD 1,146.2 Million in 2019 and is projected to reach USD 1,436.8 Million by 2027, expanding at a CAGR of 2.7% during the forecast period. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID), which is considered as one of the safest conventional by spontaneous adverse drug reaction reporting systems in the UK. It is a kind of medication having analgesic, anti-inflammatory effects, antiplatelet effect, and fever-reducing properties that can be used for conditions such as headache, toothache, fever, back pains, arthritis, minor injuries, and menstrual cramps. It works by blocking the body’s production of certain natural substance such as prostaglandins, which are released by the body in response to an illness or an injury. Prostaglandins results in inflammation, pain, swelling, or fever in a human body. The World Health Organization (WHO) considers ibuprofen in the list of minimum medical needs for a basic healthcare system.
Market Dynamics
The market is driven by several advantages that the ibuprofen drug offers such as rapid result. Ibuprofen is considered to be essential in the treatment of neurodegenerative diseases. Furthermore, the continuous rising incidence of menstrual cramps (dysmenorrhea), osteoarthritis, rheumatoid arthritis, juvenile idiopathic arthritis, and various types of pains and aches. Additionally, ibuprofen is an over the counter (OTC) drug making it easily accessible and available for usage among the end-users. This is resulting in the expansion of the global ibuprofen market.
Segmental Outlook
On the basis of type, the global Ibuprofen market is bifurcated into USP and EP. The USP segment is anticipated to hold 59.1% of the overall market due to prevalence of numerous diseases in North America. The EP segment is estimated to expand at a significant CAGR during the forecast period owing to increasing number of research laboratories in several countries in Europe.
Based on dosage forms, the market is segmented into tablet, capsule, suspension, and others. The tablet segment is projected to grow at a significant pace during the forecast period owing to the introduction of flavored chewable tablets that are mostly preferred among the infants. The capsule segment is also expected to increase at a substantial CAGR due to its property of easier swallowing while also avoiding a bad taste to the mouth.
Definitions
By Types
USP: USP abbreviation of United States Pharmacopeia, is an official pharmacopeia of the US, which was established in 1820. The pharmacopeia contains set of legally recognized standards of identity, strength, quality, purity, packaging, and labeling for drug substances, dosage forms, and other therapeutic products, including nutritionals and dietary supplements. According to, National Institutes of Health (NIH), Ibuprofen Tablets, USP comprise the active ingredient ibuprofen, which is propionic acid. Ibuprofen is a white powdered drug having melting point between 74°C and 77°C, that is to some extent soluble in water and readily soluble in organic solvents that includes ethanol and acetone. The ibuprofen tablets and USP are available in 400mg, 600mg, and 800mg tablets for the purpose of oral administration.
EP: The European Pharmacopoeia (EP) is a major regional pharmacopoeia that provides standards across the pharmaceutical industry in Europe for quality control of the medicines while also checking the quality of the constituents used to manufacture the drugs. According to the European pharmacopoeia, ibuprofen is white or almost white, crystalline powder or colorless crystals that are practically insoluble in water, while easily soluble in acetone, methanol and in methylene chloride. It dissolves in dilute solutions of carbonates and alkali hydroxides.
By Dosage Forms
Tablet: Ibuprofen tablets are generally available in weights such as 200mg, 400mg, 600mg, and 800mg. The standards of the ibuprofen tablets are either according to the United States Pharmacopoeia (USP) or Europe Pharmacopoeia (EP). Tablets are generally harder to swallow among children and can also cause a bad aftertaste, but the introduction of flavored chewable ibuprofen tablets has resulted in surging the demand for tablets segment. It has also made tablets easier to swallow just by chewing it while also providing a decent aftertaste to the mouth due to its flavor.
Capsule: Ibuprofen liquid gel capsules are generally found in 200mg and 400mg dose strength, which are recommended for adults over 12 years of age. Capsules are easier to swallow than tablet pills and avoid bad taste in the mouth, which increases their preference among patients. Capsules are comparatively faster to dissolve than tablets as tablet pills have to be broken down completely to dissolve which takes longer time.
Suspension: Ibuprofen suspension are found with different dosage strengths for relieving moderate pain, post-immunization pyrexia, symptomatic relief of headache, earache, dental pain, and backache. It is also effective in the relief of feverishness, symptoms of cold and influenza. The ibuprofen suspension is only recommended for oral administration and short-term. Adults and children over 12 years are recommended with dose of 200mg-400mg (10ml-20ml). The recommended dose for infants of age group between 3 months and 1 year is 2.5ml, and for children of age group 1-4 years, 4-7 years, and 7-12 years the recommended dosage of ibuprofen suspension is 5ml, 7.5ml, and 10ml respectively.
Others: The others category of the dosage form segment includes soluble ibuprofen, syrups, and sprays. Soluble ibuprofen produces a great peak plasma concentration of ibuprofen than the tablet. Soluble ibuprofen is generally of powdered form or granular form which can be consumed by mixing it in water.
The liquid syrup ibuprofen is primarily consumed among children aging between 3 months and 12 years. Ibuprofen syrups are proven to efficacious at managing pain after a tonsillectomy. However, soluble ibuprofen is preferred post-tonsillectomy, as tables are harder to swallow.
Ibuprofen also has its dosage forms as sprays which are non-sticky, non-greasy, and colorless in nature. These are particularly formulated to allow quick absorption of ibuprofen through the skin for effective relieve at the point of pain.
Regional Outlook
In terms of regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a promising region for the market. The region constituted around one third share of the market in 2019. The market in the region is projected to expand at a substantial CAGR during the forecast period. Increasing population and rising cancer ailments in the region are major factors the ibuprofen market in Asia Pacific. The market in Asia Pacific is projected to expand at a CAGR of approximately 3.0% due growing prevalence of cardiovascular diseases in the region.
Competitive Landscape
- Key players in the market include BASF SE, Granules India Limited (Granules Biocause), IOL Chemicals and Pharmaceuticals Limited., SI Group, Inc., Strides Pharma Science Limited., Xinhua Pharm, and Zhejiang Hisoar Pharmaceutical Co.,LTD. These companies are considered manufacturers of Ibuprofen based on their revenue, research development (R&D) activities, regional presence, and supply chain management system.
- The players are adopting key strategies such as acquisition, and geographical expansion where potential opportunity for the Ibuprofen extraction is added in the company’s capacity.
- For instance, in 2017, BASF announced plans to invest around 200 million euros (USD 232.7 million) in a new ibuprofen plant at its headquarters in Ludwigshafen in Germany and to expand the Bishop site’s production capacity. The new facility in Germany was scheduled to come online in 2021.
- In 2018, Xinhua Pharma acquired three ibuprofen applications from AiPing Pharmaceutical, Inc. the later company retained sales and distribution rights in the U.S. AiPing Pharmaceutical, Inc. is a US-based pharmaceutical company, engaged in the development, manufacturing, and distribution of pharmaceutical products.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global Ibuprofen Market
- Historical, Current and Projected Market Size in Terms of Value
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on Global Ibuprofen Market Performance
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ibuprofen Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ibuprofen Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ibuprofen Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ibuprofen Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ibuprofen Market Size & Forecast, 2017-2027
4.5.1 Ibuprofen Market Size and Y-o-Y Growth
4.5.2 Ibuprofen Market Absolute $ Opportunity
4.6 Global Ibuprofen Market: Impact Of Key Regulations
Chapter 5 Global Ibuprofen Market Analysis and Forecast By Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Type
5.1.2 Basis Point Share (BPS) Analysis By Type
5.1.3 Absolute $ Opportunity Assessment By Type
5.2 Ibuprofen Market Size & Volume Forecast By Type
5.2.1 USP
5.2.2 EP
5.3 Market Attractiveness Analysis By Type
Chapter 6 Global Ibuprofen Market Analysis and Forecast By Dosage Form
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Dosage Form
6.1.2 Basis Point Share (BPS) Analysis By Dosage Form
6.1.3 Absolute $ Opportunity Assessment By Dosage Form
6.2 Ibuprofen Market Size & Volume Forecast By Dosage Form
6.2.1 Tablet
6.2.2 Capsule
6.2.3 Suspension
6.2.4 Others
6.3 Market Attractiveness Analysis By Dosage Form
Chapter 7 Global Ibuprofen Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ibuprofen Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ibuprofen Analysis and Forecast
9.1 Introduction
9.2 North America Ibuprofen Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ibuprofen Market Size & Volume Forecast By Type
9.6.1 USP
9.6.2 EP
9.7 Basis Point Share (BPS) Analysis By Type
9.8 Absolute $ Opportunity Assessment By Type
9.9 Market Attractiveness Analysis By Type
9.10 North America Ibuprofen Market Size & Volume Forecast By Dosage Form
9.10.1 Tablet
9.10.2 Capsule
9.10.3 Suspension
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis By Dosage Form
9.12 Absolute $ Opportunity Assessment By Dosage Form
9.13 Market Attractiveness Analysis By Dosage Form
Chapter 10 Europe Ibuprofen Analysis and Forecast
10.1 Introduction
10.2 Europe Ibuprofen Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ibuprofen Market Size & Volume Forecast By Type
10.6.1 USP
10.6.2 EP
10.7 Basis Point Share (BPS) Analysis By Type
10.8 Absolute $ Opportunity Assessment By Type
10.9 Market Attractiveness Analysis By Type
10.10 Europe Ibuprofen Market Size & Volume Forecast By Dosage Form
10.10.1 Tablet
10.10.2 Capsule
10.10.3 Suspension
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis By Dosage Form
10.12 Absolute $ Opportunity Assessment By Dosage Form
10.13 Market Attractiveness Analysis By Dosage Form
Chapter 11 Asia Pacific Ibuprofen Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ibuprofen Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ibuprofen Market Size & Volume Forecast By Type
11.6.1 USP
11.6.2 EP
11.7 Basis Point Share (BPS) Analysis By Type
11.8 Absolute $ Opportunity Assessment By Type
11.9 Market Attractiveness Analysis By Type
11.10 Asia Pacific Ibuprofen Market Size & Volume Forecast By Dosage Form
11.10.1 Tablet
11.10.2 Capsule
11.10.3 Suspension
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis By Dosage Form
11.12 Absolute $ Opportunity Assessment By Dosage Form
11.13 Market Attractiveness Analysis By Dosage Form
Chapter 12 Latin America Ibuprofen Analysis and Forecast
12.1 Introduction
12.2 Latin America Ibuprofen Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ibuprofen Market Size & Volume Forecast By Type
12.6.1 USP
12.6.2 EP
12.7 Basis Point Share (BPS) Analysis By Type
12.8 Absolute $ Opportunity Assessment By Type
12.9 Market Attractiveness Analysis By Type
12.10 Latin America Ibuprofen Market Size & Volume Forecast By Dosage Form
12.10.1 Tablet
12.10.2 Capsule
12.10.3 Suspension
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis By Dosage Form
12.12 Absolute $ Opportunity Assessment By Dosage Form
12.13 Market Attractiveness Analysis By Dosage Form
Chapter 13 Middle East & Africa (MEA) Ibuprofen Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ibuprofen Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ibuprofen Market Size & Volume Forecast By Type
13.6.1 USP
13.6.2 EP
13.7 Basis Point Share (BPS) Analysis By Type
13.8 Absolute $ Opportunity Assessment By Type
13.9 Market Attractiveness Analysis By Type
13.10 Middle East & Africa (MEA) Ibuprofen Market Size & Volume Forecast By Dosage Form
13.10.1 Tablet
13.10.2 Capsule
13.10.3 Suspension
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis By Dosage Form
13.12 Absolute $ Opportunity Assessment By Dosage Form
13.13 Market Attractiveness Analysis By Dosage Form
Chapter 14 Competition Landscape
14.1 Ibuprofen Market: Competitive Dashboard
14.2 Global Ibuprofen Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BASF SE
14.3.2 Granules India Limited (Granules Biocause)
14.3.3 IOL Chemicals And Pharmaceuticals Limited.
14.3.4 SI Group, Inc.
14.3.5 Strides Pharma Science Limited.
14.3.6 Xinhua Pharm
14.3.7 Zhejiang Hisoar Pharmaceutical Co.,LTD.
By Types
- USP
- EP
- Tablet
- Capsule
- Suspension
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Italy
- U.K.
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- South East Asia (SEA)
- Rest of Asia Pacific (APAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America (LATAM)
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa (MEA)
Key Market Players Profiled in the Report
- BASF SE
- Granules India Limited (Granules Biocause)
- IOL Chemicals and Pharmaceuticals Limited.
- SI Group, Inc.
- Strides Pharma Science Limited.
- Xinhua Pharm
- Zhejiang Hisoar Pharmaceutical Co.,LTD.
Our Clients
FAQ Section
Some frequently asked quetions about this report!
Additional company profiles can be provided on request.
Yes, the report covers product specific information such as composition development etc.
According to this Growth Market Reports report, the market from Ibuprofen is likely to register a CAGR of 2.7% during forecast period 2020-2027, with an anticipated valuation of USD 1,436.8 million by the end of the 2027.
In addition to market size (in USD Million) and Company Market Share (in % for base year 2019), other data such as volume for ibuprofen and impact of key regulations is also provided. Moreover, short term and long-term outlook for the global ibuprofen market is available in final report.
The continuous rising incidence of cardiovascular diseases, cancer, trauma, arthritis, and various types of pains and aches. Additionally, ibuprofen is an over the counter (OTC) drug making it easily accessible and available for usage among the end users.
In the global market, ibuprofen is available in the form of tablets, capsules, suspensions, syrups, sprays, and others.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The market is expected to witness increment of over 4.2% between 2019 and 2020 owing to the positive impact of COVID-19 pandemic on the Ibuprofen market. The ongoing research of on COVID-19 string is expected to grow the production of Ibuprofen.
The base year considered for the global Ibuprofen market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.
Major manufactures include BASF SE, Granules India Limited (Granules Biocause), IOL Chemicals And Pharmaceuticals Limited., SI Group, Inc., Strides Pharma Science Limited., Xinhua Pharm, and Zhejiang Hisoar Pharmaceutical Co.,LTD.
Related Reports
Some other reports from this category!
